Australia clearly wanted a phase I in men. No other reason for them to do this. It could also be a combined phase 1/2, and there may be a separate phase 2 coming now in the US and Europe. At least we know why it was delayed, and they aren't waiting for regulatory decisions anymore. They can now move forward with whatever they plan to do. If they're running a ph2 concurrently in the US we'll know soon.Thank you For explanation.
But where was mentioned that Australian Agency didnt give permission For phase 2? In the News Release of Hope Medicine they Said that they will Launch Phase II in Australia :
„Its Phase II clinical trial for the treatment of androgenetic alopecia is an international multi-center, randomized, double-blind, placebo-controlled study, which is planned to be carried out in the United States, Australia and other countries.“
Last edited: